120 related articles for article (PubMed ID: 38227933)
41. Pre-transplantation vitamin E levels and acute graft-versus-host disease after non-myeloablative allogeneic hematopoietic cell transplantation.
Gjærde LK; Ostrowski SR; Jørgensen NR; Schierbeck F; Andersen NS; Friis LS; Kornblit B; Petersen SL; Schjødt I; Sengeløv H
Transpl Immunol; 2022 Oct; 74():101650. PubMed ID: 35718288
[TBL] [Abstract][Full Text] [Related]
42. Ultra low-dose IL-2 for GVHD prophylaxis after allogeneic hematopoietic stem cell transplantation mediates expansion of regulatory T cells without diminishing antiviral and antileukemic activity.
Kennedy-Nasser AA; Ku S; Castillo-Caro P; Hazrat Y; Wu MF; Liu H; Melenhorst J; Barrett AJ; Ito S; Foster A; Savoldo B; Yvon E; Carrum G; Ramos CA; Krance RA; Leung K; Heslop HE; Brenner MK; Bollard CM
Clin Cancer Res; 2014 Apr; 20(8):2215-25. PubMed ID: 24573552
[TBL] [Abstract][Full Text] [Related]
43. Peripheral Blood CD38 Bright CD8+ Effector Memory T Cells Predict Acute Graft-versus-Host Disease.
Khandelwal P; Lane A; Chaturvedi V; Owsley E; Davies SM; Marmer D; Filipovich AH; Jordan MB; Marsh RA
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1215-22. PubMed ID: 25881755
[TBL] [Abstract][Full Text] [Related]
44. Dipeptidyl Peptidase 4 Inhibition for Prophylaxis of Acute Graft-versus-Host Disease.
Farag SS; Abu Zaid M; Schwartz JE; Thakrar TC; Blakley AJ; Abonour R; Robertson MJ; Broxmeyer HE; Zhang S
N Engl J Med; 2021 Jan; 384(1):11-19. PubMed ID: 33406328
[TBL] [Abstract][Full Text] [Related]
45. Shift of graft-versus-host-disease target organ tropism by dietary vitamin A.
Koenecke C; Prinz I; Bubke A; Schreder A; Lee CW; Pabst O; Förster R
PLoS One; 2012; 7(5):e38252. PubMed ID: 22666498
[TBL] [Abstract][Full Text] [Related]
46.
Pidala J; Beato F; Kim J; Betts B; Jim H; Sagatys E; Levine JE; Ferrara JLM; Ozbek U; Ayala E; Davila M; Fernandez HF; Field T; Kharfan-Dabaja MA; Khaira D; Khimani F; Locke FL; Mishra A; Nieder M; Nishihori T; Perez L; Riches M; Anasetti C
Haematologica; 2018 Mar; 103(3):531-539. PubMed ID: 29242294
[TBL] [Abstract][Full Text] [Related]
47. Anaerobic Antibiotics and the Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
Tanaka JS; Young RR; Heston SM; Jenkins K; Spees LP; Sung AD; Corbet K; Thompson JC; Bohannon L; Martin PL; Stokhuyzen A; Vinesett R; Ward DV; Bhattarai SK; Bucci V; Arshad M; Seed PC; Kelly MS
Biol Blood Marrow Transplant; 2020 Nov; 26(11):2053-2060. PubMed ID: 32682948
[TBL] [Abstract][Full Text] [Related]
48. Immune Modulation Properties of Zoledronic Acid on TcRγδ T-Lymphocytes After TcRαβ/CD19-Depleted Haploidentical Stem Cell Transplantation: An analysis on 46 Pediatric Patients Affected by Acute Leukemia.
Merli P; Algeri M; Galaverna F; Milano GM; Bertaina V; Biagini S; Girolami E; Palumbo G; Sinibaldi M; Becilli M; Leone G; Boccieri E; Grapulin L; Gaspari S; Airoldi I; Strocchio L; Pagliara D; Locatelli F
Front Immunol; 2020; 11():699. PubMed ID: 32477328
[TBL] [Abstract][Full Text] [Related]
49. Vitamin D deficiency is not associated with graft versus host disease after hematopoietic stem cell transplantation: A meta-analysis.
Chiengthong K; Cheungpasitporn W; Thongprayoon C; Lertjitbanjong P; Cato LD; Bathini T; Ungprasert P; Mao MA; Chokesuwattanaskul R
J Evid Based Med; 2020 Aug; 13(3):183-191. PubMed ID: 32369679
[TBL] [Abstract][Full Text] [Related]
50. Comparison of ATG-thymoglobulin with ATG-Fresenius for Epstein-Barr virus infections and graft-versus-host-disease in patients with hematological malignances after haploidentical hematopoietic stem cell transplantation: a single-center experience.
Zhou L; Gao ZY; Lu DP
Ann Hematol; 2020 Jun; 99(6):1389-1400. PubMed ID: 32291495
[TBL] [Abstract][Full Text] [Related]
51. Correlation between the kinetics of CD3+ chimerism and the incidence of graft-versus-host disease in patients undergoing allogeneic hematopoietic stem cell transplantation.
Rupa-Matysek J; Lewandowski K; Nowak W; Sawiński K; Gil L; Komarnicki M
Transplant Proc; 2011 Jun; 43(5):1915-23. PubMed ID: 21693300
[TBL] [Abstract][Full Text] [Related]
52. Blockade of TIM-1 on the donor graft ameliorates graft-versus-host disease following hematopoietic cell transplantation.
Iliopoulou BP; Hsu K; Pérez-Cruz M; Tang SW; Pang WW; Erkers T; Kambham N; Freeman GJ; Dekruyff RH; Meyer EH
Blood Adv; 2019 Nov; 3(21):3419-3431. PubMed ID: 31714958
[TBL] [Abstract][Full Text] [Related]
53. Differing impacts of pretransplant serum ferritin and C-reactive protein levels on the incidence of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Sakamoto S; Kawabata H; Kanda J; Uchiyama T; Mizumoto C; Kondo T; Yamashita K; Ichinohe T; Ishikawa T; Kadowaki N; Takaori-Kondo A
Int J Hematol; 2013 Jan; 97(1):109-16. PubMed ID: 23225486
[TBL] [Abstract][Full Text] [Related]
54. Obesity induces gut microbiota alterations and augments acute graft-versus-host disease after allogeneic stem cell transplantation.
Khuat LT; Le CT; Pai CS; Shields-Cutler RR; Holtan SG; Rashidi A; Parker SL; Knights D; Luna JI; Dunai C; Wang Z; Sturgill IR; Stoffel KM; Merleev AA; More SK; Maverakis E; Raybould HE; Chen M; Canter RJ; Monjazeb AM; Dave M; Ferrara JLM; Levine JE; Longo DL; Abedi M; Blazar BR; Murphy WJ
Sci Transl Med; 2020 Nov; 12(571):. PubMed ID: 33239390
[TBL] [Abstract][Full Text] [Related]
55. Phase 3 clinical trial of steroids/mycophenolate mofetil vs steroids/placebo as therapy for acute GVHD: BMT CTN 0802.
Bolaños-Meade J; Logan BR; Alousi AM; Antin JH; Barowski K; Carter SL; Goldstein SC; Hexner EO; Horowitz MM; Lee SJ; Levine JE; MacMillan ML; Martin PJ; Mendizabal AM; Nakamura R; Pasquini MC; Weisdorf DJ; Westervelt P; Ho VT
Blood; 2014 Nov; 124(22):3221-7; quiz 3335. PubMed ID: 25170121
[TBL] [Abstract][Full Text] [Related]
56. Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease: results of a randomized trial.
Lee SJ; Zahrieh D; Agura E; MacMillan ML; Maziarz RT; McCarthy PL; Ho VT; Cutler C; Alyea EP; Antin JH; Soiffer RJ
Blood; 2004 Sep; 104(5):1559-64. PubMed ID: 15138163
[TBL] [Abstract][Full Text] [Related]
57. Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203).
Bolaños-Meade J; Reshef R; Fraser R; Fei M; Abhyankar S; Al-Kadhimi Z; Alousi AM; Antin JH; Arai S; Bickett K; Chen YB; Damon LE; Efebera YA; Geller NL; Giralt SA; Hari P; Holtan SG; Horowitz MM; Jacobsohn DA; Jones RJ; Liesveld JL; Logan BR; MacMillan ML; Mielcarek M; Noel P; Pidala J; Porter DL; Pusic I; Sobecks R; Solomon SR; Weisdorf DJ; Wu J; Pasquini MC; Koreth J
Lancet Haematol; 2019 Mar; 6(3):e132-e143. PubMed ID: 30824040
[TBL] [Abstract][Full Text] [Related]
58. Serotherapy-Free Regimen Improves Non-Relapse Mortality and Immune Recovery Among the Recipients of αβ TCell-Depleted Haploidentical Grafts: Retrospective Study in Childhood Leukemia.
Shelikhova L; Glushkova S; Nikolaev R; Dunaikina M; Zhekhovtsova Z; Blagov S; Khismatullina R; Balashov D; Kurnikova E; Pershin D; Muzalevskii Y; Kazachenok A; Osipova E; Trakhtman P; Maschan A; Maschan M
Transplant Cell Ther; 2021 Apr; 27(4):330.e1-330.e9. PubMed ID: 33836878
[TBL] [Abstract][Full Text] [Related]
59. Mesenchymal stromal cells as prophylaxis for graft-versus-host disease in haplo-identical hematopoietic stem cell transplantation recipients with severe aplastic anemia?-a systematic review and meta-analysis.
Li R; Tu J; Zhao J; Pan H; Fang L; Shi J
Stem Cell Res Ther; 2021 Feb; 12(1):106. PubMed ID: 33541414
[TBL] [Abstract][Full Text] [Related]
60. Successful treatment of intractable gastrointestinal tract graft-vs-host disease with oral beclomethasone dipropionate in pediatric and young adult patients: Case reports.
Akahane K; Watanabe A; Somazu S; Harama D; Shinohara T; Kasai S; Oshiro H; Goi K; Hasuda N; Ozawa C; Sugita K; Inukai T
Medicine (Baltimore); 2022 Mar; 101(11):. PubMed ID: 35356922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]